Global PRMT 5 Inhibitors Market, By Disease (Heart disease, Infectious disease and Cancer), By Function (Transcriptional regulation, Cell cycle regulation and Others) By End-user (Specialty Clinics, Research & laboratories, Academic research and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

In recent years, it has been established that the protein arginine methyltransferase 5 (PRMT5), an important enzyme related to epigenetics, is a target for anticancer treatments. As a therapeutic approach, epigenetic modifiers may increase the effectiveness of chemotherapy medications. Carcinogenesis has been associated with PRMT 5, a protein arginine methyltransferase that is widely expressed in lung adenocarcinoma. The enzyme responsible for symmetric dimethylation of target protein arginine residues is called PRMT 5. It has multiple roles, such as controlling the cell cycle and transcriptional regulation. In the context of cancer, PRMT5 is frequently believed to be a tumor initiator and promoter of tumor growth. The subcellular location of PRMT5 controls its function, and this location is dynamically altered during cellular development. PRMT5 is a transcriptional repressor that has been shown to be dysregulated in a number of malignancies. It suppresses the expression of genes that encode tumour suppressors.